Abstract P3083: Trim29 Deficiency Ameliorates Viral Myocarditis By Reducing Perk Mediated Er Stress And Ros Responses

Abstract

Infections by viruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could cause viral myocarditis. Endoplasmic reticulum (ER) stress is associated with several metabolic diseases such as cardiovascular disease, diabetes and cancer. However, the immune mechanisms of ER stress regulation in controlling the pathogenesis of viral myocarditis are unclear. Here, we found that knockdown or knockout of TRIM29 significantly inhibited PERK (Protein kinase RNA-like endoplasmic reticulum kinase) mediated ER stress and apoptosis induced by cardiotropic viruses CVB3 (coxsackievirus B3) or EMCV (encephalomyocarditis virus) in human and mouse cardiomyocytes. Additionally, TRIM29 deficiency relieved ROS (Reactive oxygen species) mediated STING (Stimulator of interferon genes) inhibition to produce more type I interferon for restricting cardiotropic viruses in cardiomyocytes. Importantly, cardiomyocytes specific TRIM29 deficiency exhibited dramatic protective effects on cardiac damage, cardiac dysfunction, viral replication and promoted survival in CVB3-induced viral myocarditis model in vivo . Mechanistically, TRIM29 was shown to interact with PERK and catalyze SUMOylation for maintaining its stability, thereby promoting PERK mediated ER stress and ROS responses to induce pathogenesis of viral myocarditis. Our results indicate that TRIM29 loss-of-function in cardiomyocytes ameliorates viral myocarditis by reducing PERK mediated ER stress response and unleashing ROS-suppressed interferon response. Our data suggest the TRIM29-PERK axis is a potential therapeutic target for viral myocarditis and other ER stress-associated cardiovascular disease.